BRIEF-Allergy Therapeutics first-half revenue rises 12 pct

March 24 Mon Mar 24, 2014 3:13am EDT





* Says H1 gross revenue (excluding milestones and rebates) rises 12% to 29.9 mln stg (H1 2013: 26.6 mln stg)



* H1 operating profit increased 26 pct to 6.7 mln stg (H1 2013: 5.3 mln stg) Source text for Eikon: Further company coverage:

via Smart Health Shop Forum http://ift.tt/NJt64p